Perfumes & Cosmetics

After a successful corporate career Mr John Hallam founded ABEX Pharmaceutica (Pty) Ltd in 2006, and to this day we remain a privately-owned family-business with our roots in the South African pharmaceutical market. We are an organisation with an entrepreneurial spirit and passion for building mutually beneficial strategic partnerships, and through our commitment to excellence have been fortunate enough to grow our footprint into various international markets. Today ABEX has affiliate offices in Sydney, Shanghai, and London which include strategic joint ventures and cover our international operations in various geographies such as Europe, Africa, South East Asia, and South America. ABEX is an international company based in South Africa and, actively focussed on the development, management and commercialisation of intellectual property in the healthcare field at world class standards. We pride ourselves in our core values and in forging meaningful personal relationships with like-minded partners, which in today’s marketplace we feel has proven to be a key competitive advantage. Abex Pharmaceutica (Pty) Ltd is committed to providing medicines, medical devices and related services that not only meet but consistently exceed customer expectations, while also complying with relevant regulatory and legal requirements; continually improve in everything we do, according to measurable objectives; supplying medicines and medical devices that meet the defined standards of quality, safety, efficacy and performance; adhering to an effective Quality Management System that benefits all our stakeholders and meets the latest cGMP and ISO 13485 and ISO 9001 requirements. implementing a robust Vigilance System focused on enhancing patient safety by actively monitoring and reducing risks associated with all our medicines and medical devices. – Edward Hallam, Chief Executive Officer

The establishment of Wrapsa as a pharmaceutical contract manufacturing and packing concern in 1983 was a landmark event in the history of the South African Pharmaceutical industry. This pioneering venture, aimed at providing one of the first third-party pharmaceutical manufacturing and packing services in the country, succeeded in creating strong foundations on which the Wrapsa team has, since 1983, built a thriving operation with an infrastructure and skills base worthy of international recognition. Another strategy implemented early on that has set Wrapsa apart from its growing number of competitors is to operate as a bona fida contract manufacturer and not to invest in bringing its own brands to market. The high-profile nature of much of Wrapsa’s clientele means its manufacturing and packing standards are constantly under scrutiny, with the plant subjected to customer inspections, in addition to the regular SAPHRA inspections. This is where the ISO 9001:2015 accreditation comes into play. By ensuring that our quality systems meet the criteria of the SABS for its ISO rating, and operating according to GMP guidelines, we are investing not only in our own future well being, but in that of our customers and the customers both locally and abroad who rely on the safety and efficacy of the products we manufacture.

The Kahma Healthcare Group is a diversified healthcare group that has a wide range interests that form the foundation of healthcare including, vaccines, medical consumables, dental products, pharmaceuticals and medical devices. Kahma was borne following a successful tenure by its founders in establishing one of the most diversified healthcare groups in South Africa, utilising their collective experience of over 40 years. Kahma is committed to expanding and developing healthcare in South Africa and the region, and in doing so, our aim is to contribute meaningfully to economic and healthcare development. Integrated expertise lies at the very heart of our business ethic and we are committed to combining the entrepreneurial spirit that drives expansion with serious investment in people, technology, production systems and facilities. During this tenure the business grew turnover from less than R 100 million to over R 1.5 billion through a combination of organic and acquisitive growth. During its period as a listed company the company generated a compounded annual growth rate of 28,9% before being acquired and delisted in 2016 Amongst its achievement, The Litha Healthcare Group was listed 42nd in the Sunday Times Top 100 Companies in 2014. The Sunday Times Top 100 Companies event recognises the best-performing JSE-listed companies, based on their shareholder returns and performance over a five-year period.

At FCC, we provide high quality active pharmaceutical ingredients that are used to improve patients’ lives worldwide. While doing so, we protect our employees, the environment and our products. With quality, compliance and collaboration at the core of our DNA, we continuously strive to improve and provide the ultimate solutions for our customers. Our proactive quality and safety culture is firmly rooted in our people: a workforce of over 400 employees who are energetic, committed and enthusiastic. We understand your needs and contribute proactively by offering more efficient green alternatives. Our people form a powerful basis for every new, sustainable development in our continuous drive to provide unprecedented and unique solutions. Our inexhaustible, deep-rooted foundation for complex, powerful APIs is built on 60 years of history. We are known as a reliable API provider. This is endorsed by our customers, as well as international regulatory authorities, including the US FDA, EDQM, and PMDA. Weekly we welcome (virtual) inspection teams to our sites and take pride in successfully completed inspections. We strongly believe in the chemistry of collaboration at all stages of API production. Whether your project is for a new chemical entity (NCE), or a process for (re-)designing your (intermediate) API, we will partner with you from the development phase to the commercial implementation. Our team of highly skilled experts journey with you every step of the way through personal interaction, co-creation and tailor-made solutions to ensure that your project is a success.

As a global healthcare company, with a focus on cancer pain management and specialty care therapeutic areas, we strive to ensure optimal healthcare solutions for healthcare practitioners, caregivers and patients around the world at a time in their lives when it matters most.  As a global healthcare company, with a focus on cancer pain management and specialty care therapeutic areas, we strive to ensure optimal healthcare solutions for healthcare practitioners, caregivers and patients around the world at a time in their lives when it matters most. Our medicines and therapeutic areas include anti-infectives, oncology, pain management with a focus on cancer and supportive care, biosimilars, respiratory, central nervous system (CNS) and ophthalmology.